Alston & Bird LLP advised TG Therapeutics on the deal, while Cravath represented the underwriters. TG Therapeutics, a biopharmaceutical company developing novel treatments for certain blood…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
